Family-Based Financial Incentives Intervention for Smoking Cessation
Launched by MAYO CLINIC · Aug 13, 2024
Trial Information
Current as of September 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people quit smoking by involving their family members. Specifically, it looks at how financial incentives can encourage both Alaska Native and American Indian families to support someone in their efforts to stop smoking. The trial will compare the success of participants receiving these incentives to those who do not receive them, checking for confirmed smoking abstinence at 6 and 12 months after the intervention.
To be eligible for this study, you need to be at least 18 years old, identify as Alaska Native or American Indian, and have smoked in the past week. You should also be willing to quit smoking and have a family member who can join you in the study. Participants will use a mobile phone or tablet to take part in the study activities and may receive payments for their involvement. If you join, you can expect support from your family and the study team, and there will be interviews after the trial to gather feedback from participants and health professionals to improve the program.
Gender
ALL
Eligibility criteria
- Index Participant Inclusion Criteria:
- • Alaska Native/American Indian (ANAI) person (based on self-reported race) and reside in Alaska.
- • Age ≥18 years.
- • Self-report smoking in the past 7 days, biochemically verified with saliva cotinine ≥ 30 ng/mL (positive result based on at-home saliva swab test provided by study team).
- • Smoked ≥ 3 cigarettes per day over the past 3 months.
- • Considering or willing to make a quit attempt.
- • Have or will nominate one adult family member to enroll with them.
- • Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration
- • Willing to upload photos of self during completion of smoking status tests.
- • Willing to complete and sign an Internal Revenue Service (IRS) W-9 tax identification form if they wish to receive payments on the study.
- • Willing to provide written informed consent and participate in study-related tests and procedures.
- Index Participant Exclusion Criteria:
- • Used pharmacotherapy or a stop smoking program within the past 3 months.
- • Already enrolled in the study with another family member.
- • Self-report current marijuana smoking more than once per week and are not willing to quit for the study duration (interferes with breath test).
- • Participated in a prior study phase.
- Family Member Participant Inclusion Criteria (regardless of smoking status or residence with the index participant):
- • Age ≥18 years.
- • Defined as family and nominated by the index participant, or have an ANAI family member who is ≥18 years and smokes that they would like to support in quitting.
- • Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration.
- • Willing to complete and sign an IRS W-9 tax identification form if they wish to receive payments on the study.
- • Willing to provide written informed consent and participate in study related tests and procedures.
- • Both men and women, those from non-ANAI racial/ethnic groups, and those who live outside of Alaska in the United States will be eligible family member participants.
- Family Member Participant Exclusion Criteria:
- • Already enrolled with another family member.
- • Participated in a prior study phase.
- • After the randomized controlled trial, qualitative interviews will be conducted with index participants, family member participants, and Alaska Tribal Health System Stakeholders to inform program implementation. Healthcare providers, cessation specialists, Elder advisors, and Tribal Health System leaders and stakeholders will be invited by the Alaska Native Tribal Health Consortium team and separately consented and interviewed.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Anchorage, Alaska, United States
Patients applied
Trial Officials
Christi A Patten, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported